Compounding Pharmacy Results Unfolding

State legislatures across the nation have increased oversight in how they regulate specialty pharmacies after House hearings last week in the case of a Massachusetts compounding pharmacy faulted for distributing the tainted steroids that caused a deadly meningitis outbreak in October. Some states will toughen inspections of in-state facilities and others are considering harsher license requirements for specialty drugs brought in from out-of-state facilities. Testifying at the hearings, an FDA representative brought up increased federal oversight, although there has been no formal proposal for such measures. A spokesman for the International Academy of Compounding Pharmacists says it is too soon to tell whether anything will pass on a federal level, but says compounding pharmacies are an important resource to those who may be allergic to or who may not have access to the pharmaceuticals they need. (Reporter Elizabeth Gillis)

LISTEN: MA Compounding Pharmacy Results Unfolding